Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.

Authors: Lee, Eunjung; Ma, Huiyan; McKean-Cowdin, Roberta; Van Den Berg, David; Bernstein, Leslie; Henderson, Brian E; Ursin, Giske

Published In Cancer Epidemiol Biomarkers Prev, (2008 Nov)

Abstract: Multiparity and breast-feeding reduce breast cancer risk, whereas oral contraceptive use may slightly increase breast cancer risk in the general population. However, the effects of these factors in BRCA1 and BRCA2 mutation carriers are less clear.Case patients were 1,469 women from Los Angeles County ages 20 to 49 years with newly diagnosed breast cancer. Control subjects were 444 women without breast cancer, individually matched to a subset of cases on race, age, and neighborhood. BRCA1/2 genes were sequenced in the cases, and odds ratios of breast cancer associated with various reproductive and hormonal factors in BRCA1/2 mutation carriers and noncarriers were estimated using multivariable logistic regression.Ninety-four women had a deleterious BRCA1 or BRCA2 mutation. Number of full-term pregnancies was inversely associated with breast cancer risk regardless of BRCA1/2 mutation status. Longer breast-feeding duration was protective among noncarriers but not among mutation carriers; however, this apparent effect modification was not statistically significant (P = 0.23). Neither oral contraceptive use overall nor the use of low-dose oral contraceptives was associated with an increased risk of breast cancer in any subgroup.Our results suggest that parity protects against breast cancer in BRCA1/2 mutation carriers, whereas breast-feeding does not. Our data suggest no association between oral contraceptive use and breast cancer risk in BRCA1/2 mutation carriers. Further confirmation that currently available low-dose oral contraceptives do not increase breast cancer risk in carriers is important from a public health perspective given the high prevalence of oral contraceptive use in the United States.

PubMed ID: 18990759 Exiting the NIEHS site

MeSH Terms: Adult; Analysis of Variance; Breast Feeding*; Breast Neoplasms/chemically induced*; Breast Neoplasms/epidemiology; Breast Neoplasms/genetics*; Case-Control Studies; Chi-Square Distribution; Contraceptives, Oral, Hormonal/administration & dosage*; Contraceptives, Oral, Hormonal/adverse effects; Drug Administration Schedule; Female; Genes, BRCA1; Genes, BRCA2; Humans; Logistic Models; Los Angeles/epidemiology; Middle Aged; Mutation*; Parity*; Pregnancy; Registries; Risk Assessment; Risk Factors

to Top